CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 114 enrolled
Drug / intervention
Tranexamic acid 5% +1 moredrug
Likely dose
Tranexamic acid 5% 100 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02903017
NCT02903017Phase 4Completed
CompareCT.gov

Local Administration of Tranexamic Acid in Upper Gastrointestinal Hemorrhage: A Double-Blind, Randomized, Placebo-Controlled Trial

Kocaeli University·interventional·Posted Sep 16, 2016·Updated Mar 6, 2018

In Brief

A Phase 4 clinical trial evaluating Tranexamic acid 5% and Placebo for Gastrointestinal Hemorrhage and 3 related conditions. Completed, enrolled 114 participants across 1 site.

Detailed Summary

Upper gastrointestinal hemorrhage is a frequently diagnosis in emergency departments. Although new drugs and endoscopic techniques were easily applied in various settings in this condition, the role of local administered therapies such as antifibrinolytic agents remain unclear. The investigators aimed to compare standard therapy (proton pump inhibitors, endoscopic treatments etc.) and standard therapy + local administered tranexamic acid in upper gastrointestinal hemorrhage in a double-blind, randomized trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Hemorrhage, Tranexamic Acid, Emergency Department, Antifibrinolytic Agents
CountriesTurkey (Türkiye)
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedSep 16, 2016
Enrollment StartSep 1, 2016
Primary CompletionMar 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.8 years ago

Interventions

Tranexamic acid 5%drug

Via nasogastric tube, 100 mL

Placebodrug

Via nasogastric tube, 100 mL